Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Remodulin® (treprostinil) – New warnings
June 8, 2018 - The FDA approved updates to the Warnings and Precautions section of the Remodulin (treprostinil) drug label regarding risk of symptomatic hypotension and risk of bleeding.
